Skip to main content

Featured

Global Markets Rattle as Oil Spikes and U.S. Futures Sink Amid Escalating Middle East Conflict

  Markets are sliding as geopolitical tensions intensify, with U.S. stock futures turning sharply lower and oil prices surging above the $100 mark. Investors are reacting to escalating conflict in the Middle East, which is raising fears of disrupted energy supplies and renewed inflation pressures.  Market Overview Dow Jones futures fell roughly 0.8% , extending a multi‑day downturn. S&P 500 and Nasdaq futures each slipped about 0.6% , paring earlier, deeper losses.  The declines reflect mounting investor anxiety as geopolitical risks overshadow recent economic data. Oil Surges on Supply Fears Crude oil spiked above $100 per barrel before easing slightly. The surge followed Iran’s expanded attacks on energy infrastructure , prompting Iraq to close key oil terminals after tanker strikes.  Higher oil prices are stoking concerns about inflation , complicating expectations for future Federal Reserve policy. What’s Driving the Selloff The widening Mi...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments